|
MultiTarget Pharmaceuticals
bigi 4a-d Bigi 4a D, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multitarget-directed+ligands+bigi+4a-d/pm36615267-0-1-1?v=MultiTarget+Pharmaceuticals Average 90 stars, based on 1 article reviews
bigi 4a-d - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
MultiTarget Pharmaceuticals
multitarget-directed ligands bigi 5a-d ![]() Multitarget Directed Ligands Bigi 5a D, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/multitarget-directed+ligands+bigi+4a-d/pmc09822022-46-3-3?v=MultiTarget+Pharmaceuticals Average 90 stars, based on 1 article reviews
multitarget-directed ligands bigi 5a-d - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Design of multitarget-directed ligands BIGI 4a-d and BIGI 5a-d .
Article Snippet: Thus, the new
Techniques:
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Synthesis of targeted multitarget-directed ligands BIGI 4a-d and BIGI 5a-d using one-pot Biginelli reaction.
Article Snippet: Thus, the new
Techniques:
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Cholinesterases inhibition, calcium blockade percentages, and ORAC (TE) values for compounds BIGI 4a-d and BIGI 5a-d compared with reference compounds.
Article Snippet: Thus, the new
Techniques: Inhibition
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Nrf2 transcriptional activation potencies of compounds BIGI 4b ( A ), BIGI 4d ( B ), BIGI 5b ( C ), and BIGI 5d ( D ) or reference compound TBHQ I ( E ). Data are means ± SEM of at least 3 different experiments. * p ≤ 0.05 and *** p ≤ 0.001 with respect to non-treated cells (control cells).
Article Snippet: Thus, the new
Techniques: Activation Assay, Control
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Nrf2 induction potencies of compounds BIGI 4b , BIGI 4d , BIGI 5b , and BIGI 5d and reference compound TBHQ in Nrf2/ARE-luciferase reporter cells.
Article Snippet: Thus, the new
Techniques:
Journal: Molecules
Article Title: Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca 2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
doi: 10.3390/molecules28010071
Figure Lengend Snippet: Physicochemical properties of the synthesized compounds calculated by Data Warrior.
Article Snippet: Thus, the new
Techniques: Synthesized